Akanda Corp. (AKAN) vs Petros Pharmaceuticals, Inc. (PTPI)

Akanda Corp. and Petros Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. is the larger, with a market value of $2.2M against $1.0M — 2.2× the size. Across the 7 metrics below, Akanda Corp. leads on 5 and Petros Pharmaceuticals, Inc. on 2.

Valuation

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
P/E — n/m 20.45
P/S — n/m 2.11
P/B n/m n/m 1.69
Price to free cash flow n/m n/m 15.98
EV/EBITDA n/m n/m 12.21
EV/Sales n/m 0.62 2.79
Earnings yield — 0.00% (15.61%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Gross margin — 118.32% 53.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% (2.31%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (710.28%) (0.80%)
Return on assets 0.00% (334.15%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (12.20%) 5.22%
EPS growth (last fiscal year) (139.63%) 98.13% 42.91%
Revenue growth, 5-year CAGR 161.77% (19.98%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) 0.00 0.04
Current ratio 0.22 1.25 2.46
Net debt to EBITDA (2.75) 1.11 1.01

Dividend

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.47%
Payout ratio — — 0.28

Size

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Market cap 2.24m 1.04m 300.78m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack